Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 201–300 of 1,000
Zhang, Z., Teoh, S., Hui, J. H. P., Fisk, N. M., Choolani, M. A., & Chan, J. K. Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.025 · Cited by 165
“tissue-intrinsic stem or progenitor cells [19,78,97,108,109,114].”
Burdon, T. J., Paul, A., Noiseux, N., Prakash, S., & Shum‐Tim, D. (2010) · Bone Marrow Research · doi:10.1155/2011/207326 · Cited by 170
Self-citationStem cell therapy for ischemic heart diseases
Yu, H., Lu, K., Zhu, J., & Wang, J. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldw059 · Cited by 159
Marolt, D., Traweger, A., Gimona, M., & Redl, H. R. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00352 · Cited by 175
“The paracrine action of MSCs was shown by Gnecchi et al., demonstrating that application of MSC-conditioned medium ameliorated tissue damage in a rodent model of acute myocardial infarction (Gnecchi et al., 2005).”
BackgroundLai, R. C., Arslan, F., Tan, S. S., Tan, B., Choo, A. B. H., Lee, M. M., Chen, T. S., Teh, B. J., Eng, J. K. L., Sidik, H., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.12.021 · Cited by 156
“Some reports have suggested that factors secreted by MSCs [10] were responsible for the therapeutic effect on arteriogenesis [11], stem cell crypt in the intestine [12], ischemic injury [9,13–18], and hematopoiesis [19,20].”
BackgroundMesenchymal stem cell therapy for heart disease
Gnecchi, M., Danieli, P., & Cervio, E. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.04.002 · Cited by 174
“…MSC transfer in animal models of cardiac injury might be related to secretion of soluble factors that, acting in a paracrine fashion, protect the heart, cause attenuation of pathological ventricular remodeling, and promote neovascularization (Gnecchi et al., 2005, 2006; Kinnaird et al., 2004b).”
BackgroundSelf-citationMerritt, E. K., Cannon, M. V., Hammers, D. W., Le, L. N., Gokhale, R., Sarathy, A., Song, T. J., Tierney, M. T., Suggs, L. J., Walters, T. J., et al. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0826 · Cited by 149
Zhu, W., Zhao, M., Mattapally, S., Chen, S., & Zhang, J. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.311504 · Cited by 162
Exploiting Advanced Hydrogel Technologies to Address Key Challenges in Regenerative Medicine
Foyt, D. A., Norman, M. D. A., Yu, T. T. L., & Gentleman, E. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700939 · Cited by 150
Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration
Cattelan, G., Guerrero Gerbolés, A., Foresti, R., Pramstaller, P. P., Rossini, A., Miragoli, M., & Caffarra Malvezzi, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00414 · Cited by 152
“, 2008); their impact was mainly related to an hypoxia-dependent secretion of several cytokines, chemokines, and growth factors, that not only exert a cytoprotective effect on cardiomyocytes survival (Gnecchi et al., 2005), but lead also to an increase in collateral perfusion through paracrine stimulation of prolifera…”
BackgroundCrivelli, B., Chlapanidas, T., Perteghella, S., Lucarelli, E., Pascucci, L., Brini, A. T., Ferrero, I., Marazzi, M., Pessina, A., & Torre, M. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.023 · Cited by 164
Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
“Various groups have shown that MSCs secrete proangiogenic factors (Kinnaird et al. , 2004a,b; Gnecchi et al. , 2005, 2008).”
InfluentialSelf-citationCardiogenic Differentiation and Transdifferentiation of Progenitor Cells
Reinecke, H., Minami, E., Zhu, W., & Laflamme, M. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.180588 · Cited by 151
Preclinical Studies of Stem Cell Therapy for Heart Disease
Tompkins, B. A., Balkan, W., Winkler, J., Gyöngyösi, M., Goliasch, G., Fernández‐Avilés, F., & Hare, J. M. (2018) · Circulation Research · doi:10.1161/circresaha.117.312486 · Cited by 160
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications
van de Wakker, S. I., Meijers, F. M., Sluijter, J. P. G., & Vader, P. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000841 · Cited by 155
“Furthermore, EVs are the active component of the paracrine secretion of progenitor cells to stimulate cardiac repair (Gnecchi et al., 2005; Lai et al., 2010; Barile et al., 2014; Ibrahim et al., 2014; Maring et al., 2019; Yang et al., 2019).”
BackgroundThe role of microRNAs in self-renewal and differentiation of mesenchymal stem cells
Guo, L., Zhao, R. C., & Wu, Y. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.011 · Cited by 165
“It has been recognized that MSCs promote tissue repair/ regeneration through release of diverse growth factors, cytokines, and extracellular matrix molecules [93–96].”
BackgroundFive Decades Later, Are Mesenchymal Stem Cells Still Relevant?
Gomez-Salazar, M. A., Gonzalez-Galofre, Z. N., Casamitjana, J., Crisan, M., James, A. W., & Péault, B. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00148 · Cited by 155
Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells
Wang, J., Chen, T., Jiang, J., Shi, H., Gui, C., Luo, R., Xie, X.-J., Xiang, M., & Zhang, X. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00716.x · Cited by 157
Zentilin, L., Tafuro, S., Zacchigna, S., Arsic, N., Pattarini, L., Sinigaglia, M., & Giacca, M. (2006) · Blood · doi:10.1182/blood-2005-08-3215 · Cited by 149
Patching the Heart: Cardiac Repair From Within and Outside
Ye, L., Zimmermann, W., Garry, D. J., & Zhang, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300216 · Cited by 155
Sharma, S., Mishra, R., Bigham, G. E., Wehman, B. P., Khan, M. M., Xu, H., Saha, P., Goo, Y. A., Datla, S. R., Chen, L., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309782 · Cited by 153
Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
Hoogduijn, M. J., & Lombardo, E. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0073 · Cited by 151
Cardiac Cell Repair Therapy: A Clinical Perspective
Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., & Terzic, A. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.10.876 · Cited by 149
A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome
Gallina, C., Turinetto, V., & Giachino, C. (2015) · Stem Cells International · doi:10.1155/2015/765846 · Cited by 152
“MSCs-induced stimulation of endogenous CSCs via direct cell-cell interaction [16] and MSCs-dependent paracrine signaling [17, 20] remain two other possible cardiac regeneration mechanisms.”
BackgroundMesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration
Sagaradze, G. D., Basalova, N. A., Efimenko, A. Y., & Va, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576176 · Cited by 149
“The observed effects were achieved in a short time, which additionally reinforced the hypothesis (Gnecchi et al., 2005).”
BackgroundDental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
Bar, J. K., Lis-Nawara, A., & Grelewski, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112018 · Cited by 142
“[63] allow the theory to be revisited that the therapeutic applicability of MSCs in regenerative medicine is based on their capability of homing to the tissue injury site and differentiate into different functional cell types, leading to tissue repair.”
BackgroundKim, S.-W., Kim, S., Cho, H., Lee, J.-U., Levit, R. D., & Yoon, Y. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.070 · Cited by 142
Oñate, B., Vilahur, G., Ferrer‐Lorente, R., Ybarra, J., Díez‐Caballero, A., Ballesta‐López, C., Moscatiello, F., Herrero, J., & Badimon, L. (2012) · The FASEB Journal · doi:10.1096/fj.12-207217 · Cited by 138
Han, J., Kim, B.-K., Shin, J.-Y., Ryu, S., 노명경, Woo, J., Park, J.-S., Lee, Y., Lee, N., Hyeon, T., et al. (2015) · ACS Nano · doi:10.1021/nn506732n · Cited by 148
Kraehenbuehl, T. P., Ferreira, L. S., Hayward, A. M., Nahrendorf, M., van der Vlies, A. J., Vasile, E., Weissleder, R., Langer, R., & Hubbell, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.005 · Cited by 141
“Studies with bone marrow- or adipose tissue-derived stem cells and progenitor cells in animals and also in human clinical evaluation suggest that both neovascularization and paracrine effects play an important role in protecting native cardiomyocytes from death, enhancing the healing processes and preserving cardiac f…”
Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature
Shimizu, Y., Ntege, E. H., Sunami, H., & Inoue, Y. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.10.005 · Cited by 145
Akt1 in the cardiovascular system: friend or foe?
O'Neill, B. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25900 · Cited by 141
Zhang, Z., Teoh, S., Chong, M. S. K., Lee, E. S. M., Tan, L. G., Mattar, C. N. Z., Fisk, N. M., Choolani, M. A., & Chan, J. K. Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.078 · Cited by 145
Halkos, M. E., Zhao, Z., Kerendi, F., Wang, N.-P., Jiang, R., Schmarkey, L. S., Martin, B. J., Quyyumi, A. A., Few, W. L., Kin, H., et al. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0741-0 · Cited by 140
“However, it has been previously reported that MSCs release a large number of growth factors and cytokines, such as stem cell factor (SCF), granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor, stromal cell-derived factor-1 (SDF-1) and IL6 among others [14, 22].”
BackgroundBeer, L., Zimmermann, M., Mitterbauer, A., Ellinger, A., Грубер, Ф., Narzt, M., Zellner, M., Gyöngyösi, M., Madlener, S., Simader, E., et al. (2015) · Scientific Reports · doi:10.1038/srep16662 · Cited by 142
Haider, K. H., & Aramini, B. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1548-7 · Cited by 141
“with the earlier observations that conditioned medium from genetically modified cells led to improved cell survival and protected the infarcted heart [53, 54].”
BackgroundAn Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use
Tieu, A., Lalu, M. M., Slobodian, M., Gnyra, C., Fergusson, D. A., Montroy, J. R., Burger, D. E., Stewart, D. J., & Allan, D. (2020) · ACS Nano · doi:10.1021/acsnano.0c01363 · Cited by 153
Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy
Zimmet, J. M., & Hare, J. M. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0553-4 · Cited by 150
Badillo, A. T., Beggs, K. J., Javazon, E. H., Tebbets, J. C., & Flake, A. W. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.447 · Cited by 153
Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L., Peng, Y., Dong, X., Huang, H., Si, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075927 · Cited by 138
“In fact, the Akt pathway is activated during hydrogen peroxide-induced apoptosis in H9c2 cells [70] and mesenchymal stem cells [71] as well as in in vivo models of DCM [51].”
BackgroundSelf-citationKidney Protection and Regeneration Following Acute Injury: Progress Through Stem Cell Therapy
Togel, F. E., & Westenfelder, C. S. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.08.034 · Cited by 146
Mesenchymal stem cells secretome: current trends and future challenges
Teixeira, F., & Salgado, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.264455 · Cited by 125
“Although promising, this theory was revisited at the beginning of the 20th century when, for the first time, Gnecchi and colleagues revealed that MSCs mediated its therapeutical effects by the secretion and release of trophic molecules, nowadays known as secretome (Gnecchi et al., 2005).”
Kenari, A. N., Cheng, L., & Hill, A. F. (2020) · Methods · doi:10.1016/j.ymeth.2020.01.001 · Cited by 151
Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair
Liu, X., Li, X., Zhu, W., Zhang, Y., Hong, Y., Liang, X., Fan, B., Zhao, H., He, H., & Zhang, F. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29456 · Cited by 140
Self-citationSkeletal Myoblasts as a Therapeutic Agent
Menasché, P. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.02.002 · Cited by 150
Shafiq, M., Jung, Y., & Kim, S. H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.020 · Cited by 147
“Conditioned medium from Akttransduced cells showed an accumulation of cardioprotective factors, which might improve cardiac function [159].”
Chow, A., Stuckey, D. J., Kidher, E. S., Rocco, M., Jabbour, R. J., Mansfield, C. A., Darzi, A. W., Harding, S. E., Stevens, M. M., & Athanasiou, T. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.003 · Cited by 137
“However, it is frequently reported that the number of grafted cells that remain within the heart is minimal at later time points (Gnecchi et al., 2005; Passier et al., 2008; Carr et al., 2011; Kawamura et al., 2012; Noseda et al., 2015).”
BackgroundFang, A., Wang, Y., Guan, N., Zuo, Y., Lin, L., Guo, B., Mo, A., Wu, Y., Lin, X., Cai, W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39745-2 · Cited by 151
Babenko, V. A., Silachev, D. N., Zorova, L. D., Pevzner, I. B., Khutornenko, A. A., Plotnikov, E. Y., Sukhikh, G. T., & Zorov, D. B. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0010 · Cited by 131
Stem cell therapy for cardiac repair: benefits and barriers
Joggerst, S. J., & Hatzopoulos, A. K. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001124 · Cited by 145
“Circulation Research 98, 1414-1421 162 Gnecchi, M. et al. (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research 103, 1204-1219 163 Hinkel, R. et al. (2008) Thymosin b4 is an essential paracrine factor of embryonic endothelial progenitor cell mediated cardioprotection.”
BackgroundInfluentialPark, B.-W., Jung, S.-H., Das, S., Lee, S. M., Park, J.-H., Kim, H., Hwang, J.-W., Lee, S., Kim, H.-J., Kim, H.-Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6994 · Cited by 133
Nooshabadi, V. T., Mardpour, S., Yousefi‐Ahmadipour, A., Allahverdi, A., Izadpanah, M., Daneshimehr, F., Ai, J., Banafshe, H. R., & Ebrahimi‐Barough, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26726 · Cited by 133
Stem cell death and survival in heart regeneration and repair
Abdelwahid, E., Kalvelytė, A. V., Stulpinas, A., de Carvalho, K. A. T., Guarita-Souza, L. C., & Földes, G. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1203-4 · Cited by 144
“On the other hand, previous reports have suggested beneficial effect of cell therapy through paracrine function and by using in vitro generated special conditioned medium [12, 37, 190, 191].”
BackgroundStubbs, S. L., Hsiao, S. T.-F., Peshavariya, H. M., Lim, S. Y., Dusting, G. J., & Dilley, R. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0289 · Cited by 129
Strategies for Cardiac Regeneration and Repair
Lin, Z., & Pu, W. T. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006681 · Cited by 141
Weber, B., Scherman, J., Emmert, M. Y., Gruenenfelder, J., Verbeek, R., Bracher, M., Black, M., Kortsmit, J., Franz, T., Schoenauer, R., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr059 · Cited by 131
Wang, J., Xia, J. L., Huang, R., Hu, Y., Fan, J., Shu, Q., & Xu, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01937-8 · Cited by 147
Extracellular Vesicles as Therapeutic Tools in Cardiovascular Diseases
Fleury, A., Martínez, M. C., & Lay, S. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00370 · Cited by 130
“Moreover, this compartmentalization may be regulated by external stimuli as illustrated by hypoxia, which can modulate immunomodulatory and regenerative properties of MSC-derived EVs (16) but also enhanced expression of pro-angiogenic miRNAs in EPC-derived EVs (43).”
BackgroundCell Delivery: Intramyocardial Injections or Epicardial Deposition? A Head-to-Head Comparison
Hamdi, H., Furuta, A., Bellamy, V., Bel, A., Puymirat, É., Peyrard, S., Agbulut, O., & Menasché, P. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.12.074 · Cited by 127
Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration
Pankajakshan, D., & Agrawal, D. K. (2014) · Journal of Biomedical Technology and Research · doi:10.19104/jbtr.2014.107 · Cited by 137
Bari, E., Perteghella, S., Catenacci, L., Sorlini, M., Croce, S., Mantelli, M., Avanzini, M. A., Sorrenti, M., & Torre, M. L. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0240 · Cited by 126
Zhang, Z., Deb, A., Zhang, Z., Pachori, A. S., He, W., Guo, J., Pratt, R. E., & Dzau, V. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.11.016 · Cited by 127
Self-citationNishiyama, N., Miyoshi, S., Hida, N., Uyama, T., Okamoto, K., Ikegami, Y., Miyado, K., Segawa, K., Terai, M., Sakamoto, M., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0662 · Cited by 135
Molecular Imaging of Embryonic Stem Cell Misbehavior and Suicide Gene Ablation
Cao, F., Drukker, M., Lin, S.-A., Sheikh, A. Y., Xie, X., Li, Z., Connolly, A. J., Weissman, I. L., & Wu, J. C. (2007) · Cloning and Stem Cells · doi:10.1089/clo.2006.0e16 · Cited by 128
“…transplanted into tissues such as the pancreas (Ramiya et al., 2000), brain (Lindvall et al., 2004), spinal cord (McDonald et al., 1999), heart (Gnecchi et al., 2005), and bone marrow (Chris-tensen et al., 2004) of rodents and primates have shown some degree of engraftment, regeneration, and…”
The therapeutic potential of mesenchymal stem cells: Cell- & Tissue-based Therapy
Picinich, S. C., Mishra, P. J., Mishra, P. J., Glod, J., & Banerjee, D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.965 · Cited by 123
Lecina, M., Ting, S., Choo, A., Reuveny, S., & Oh, S. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0104 · Cited by 123
“7 All these studies reported a partial repair of the infarcted area and an increase in cardiomyocyte (CM) survival and systolic function, and also demonstrated that somatic or adult stem cells cannot be used as source for large-scale CM production since they do not differentiate efficiently into…”
FGF21 and Cardiac Physiopathology
Planavila, A., Redondo-Angulo, I., & Villarroya, F. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00133 · Cited by 123
“Several lines of evidence indicate that communication among cardiac cells via secreted factors may contribute to myocardial hypertrophic remodeling (55, 56).”
BackgroundGnecchi, M., He, H., Melo, L. G., Noiseux, N., Morello, F., de Boer, R. A., Zhang, L., Pratt, R. E., Dzau, V. J., & Ingwall, J. S. (2009) · Stem Cells · doi:10.1002/stem.12 · Cited by 124
Self-citationKim, H. O., Choi, S.-M., & Kim, H. (2013) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-013-0010-7 · Cited by 135
“Studies showed that conditioned medium collected from MSC promotes proliferation and migration of endothelial cells and vascular smooth muscle cells in vitro, and mediates blood flow recovery of ischemic hindlimb(77) and cardiac infarction.(78,79) Similarly, injection of conditioned medium of MSC rescued rats with ful…”
BackgroundMicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1
Liu, J., van Mil, A., Vrijsen, K. R., Zhao, J., Gao, L., Metz, C. H. G., Goumans, M., Doevendans, P. A., & Sluijter, J. P. G. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01104.x · Cited by 126
“Several strategies of preconditioning or stimulations are studied [31–35].”
BackgroundJiang, D., Xiong, G., Feng, H., Zhang, Z., Chen, P., Yan, B., Chen, L., Kesavamoorthy, G., Ma, C., Li, C., et al. (2019) · Theranostics · doi:10.7150/thno.29422 · Cited by 127
“Current understanding on MSCs mediated preservation on retinal function is either through direct replacement of damaged neuron [5-9], or indirect neuroprotective factors secretion to support stressed retinal neurons [2, 10-12].”
BackgroundMesenchymal stem cells and cardiac repair
Neßelmann, C., Ma, N., Bieback, K., Wagner, W., Ho, A. D., Konttinen, Y. T., Zhang, H., Hinescu, M. E., & Steinhoff, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00457.x · Cited by 122
“They speculated that paracrine actions exerted by the cells through the release of soluble factors might be important mechanisms of tissue repair and functional improvement after injection of the Akt-MSCs [88].”
BackgroundExtracellular vesicle therapeutics for liver disease
Borrelli, D. A., Yankson, K., Shukla, N., Vilanilam, G. K., Ticer, T. D., & Wolfram, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.022 · Cited by 125
“For example, in experimental models of kidney failure, treatment with MSC-EVs led to reduced damage and improved survival [99,100], while EVs reduced injury in myocardial infarction models [101,102].”
Beohar, N., Rapp, J. A., Pandya, S., & Losordo, D. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.039 · Cited by 124
Wang, C., Cherng, W., Yang, N., Kuo, L., Hsu, C.-M., Yeh, H., Lan, Y.-J., Yeh, C., & Stanford, W. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147256 · Cited by 119
Beer, L., Mildner, M., & Ankersmit, H. J. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.50 · Cited by 128
Gleeson, B. M., Martin, K., Ali, M. T., Kumar, A. H. S., Pillai, M. G.-K., Kumar, S. P. G., O'Sullivan, J. F., Whelan, D., Stocca, A., Khider, W., et al. (2015) · Stem Cells · doi:10.1002/stem.2050 · Cited by 116
Mesenchymal Stem Cells for Cardiac Cell Therapy
Choi, Y., Kurtz, A., & Stamm, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.211 · Cited by 125
“, 2009), and can be augmented by genetic modification of MSCs (Gnecchi et al., 2005).”
Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells
Nakanishi, C., Yamagishi, M., Yamahara, K., Hagino, I., Mori, H., Sawa, Y., Yagihara, T., Kitamura, S., & Nagaya, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.074 · Cited by 129
Amniotic Fluid Stem Cells Are Cardioprotective Following Acute Myocardial Infarction
Bollini, S., Cheung, K. K., Riegler, J., Dong, X., Smart, N., Ghionzoli, M., Loukogeorgakis, S., Maghsoudlou, P., Dubé, K. N., Riley, P. R., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0424 · Cited by 118
Moisseiev, E., Anderson, J. D., Oltjen, S. L., Goswami, M., Zawadzki, R. J., Nolta, J. A., & Park, S. S. (2017) · Current Eye Research · doi:10.1080/02713683.2017.1319491 · Cited by 119
Figeac, F., Lesault, P., Coz, O. L., Damy, T., Souktani, R., Trébeau, C., Schmitt, A., Ribot, J., Mounier, R., Guguin, A., et al. (2013) · Stem Cells · doi:10.1002/stem.1560 · Cited by 121
Han, D. H., Huang, W., Li, X., Gao, L., Su, T., Li, X., Ma, S., Liu, T., Li, C., Chen, J., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12299 · Cited by 116
Biological approaches to improve skeletal muscle healing after injury and disease
Gharaibeh, B., Chun‐Lansinger, Y., Hagen, T., Ingham, S. J. M., Wright, V. J., Fu, F. H., & Huard, J. (2012) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21005 · Cited by 125
“Results indicate that repair may be due to a largely overlooked characteristic of stem cells, paracrine signaling by surviving stem cells (Gnecchi et al., 2005; Murry et al., 2006; Gharaibeh et al., 2011; Fig.”
BackgroundSalgado, A. J., Sousa, J. C., Costa, B. M., Pires, A. O., Mateus‐Pinheiro, A., Teixeira, F. G., Pinto, L., & Sousa, N. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00249 · Cited by 126
“In 2005, Gnecchi et al. (2005) put forward a new concept that lately would change the paradigm of howMSCs could be used in regenerative medicine, by showing that their therapeutic potential was mostly related to the growth factors that they secreted to the extracellular milieu, rather than to their…”
BackgroundThe future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
Mohr, A., & Zwacka, R. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.025 · Cited by 119
Nguyen, B.-K., Maltais, S., Perrault, L. P., Tanguay, J., Tardif, J., Stevens, L., Borie, M., Harel, F., Mansour, S., & Noiseux, N. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9171-0 · Cited by 123
“We and others have shown that injection of MSC-derived factors (MSC-CM) from hypoxic or serum starvation cultured MSC either directly into infarcted hearts [8, 15], by intramuscular injections [16], or by intraperitoneal injections [12] improves ventricular function in small animals MI models.”
BackgroundMethodResultInfluentialSelf-citationHypoxic Conditioning Enhances the Angiogenic Paracrine Activity of Human Adipose-Derived Stem Cells
Hsiao, S. T.-F., Lokmic‐Tomkins, Z., Peshavariya, H., Abberton, K. M., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0602 · Cited by 122
Novel application of stem cell-derived factors for periodontal regeneration
Inukai, T., Katagiri, W., Yoshimi, R., Osugi, M., Kawai, T., Hibi, H., & Ueda, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.074 · Cited by 124
“Recent studies have indicated that the paracrine effects of the growth factors and cytokines secreted from implanted MSCs may promote tissue regeneration in vivo [9,10].”
BackgroundDanieli, P., Malpasso, G., Ciuffreda, M. C., Cervio, E., Calvillo, L., Copes, F., Pisano, F., Mura, M., Kleijn, L., de Boer, R. A., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0253 · Cited by 113
Self-citationZhang, Y., Chiu, S., Liang, X., Gao, F., Zhang, Z., Liao, S.-Y., Liang, Y., Chai, Y.-H., Low, D., Tse, H., et al. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.7 · Cited by 113
Bone Marrow Mesenchymal Stromal Cells Attenuate Organ Injury Induced by LPS and Burn
Yagi, H., Soto–Gutiérrez, A., Kitagawa, Y., Tilles, A. W., Tompkins, R. G., & Yarmush, M. L. (2010) · Cell Transplantation · doi:10.3727/096368910x508942 · Cited by 121
Landázuri, N., Tong, S., Suo, J., Joseph, G., Weiss, D., Sutcliffe, D. J., Giddens, D. P., Bao, G., & Taylor, W. R. (2013) · Small · doi:10.1002/smll.201300570 · Cited by 120
Hair growth promoting effects of adipose tissue-derived stem cells
Won, C. H., Yoo, H. G., Kwon, O., Sung, M. Y., Kang, Y. J., Chung, J. H., Park, B. S., Sung, J.-H., Kim, W. S., & Kim, K. H. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.10.013 · Cited by 116
Empowering Adult Stem Cells for Myocardial Regeneration
Mohsin, S., Siddiqi, S., Collins, B. L., & Sussman, M. A. (2011) · Circulation Research · doi:10.1161/circresaha.111.243071 · Cited by 113
Mesenchymal Stem Cells Attenuate Peritoneal Injury through Secretion of TSG-6
Wang, N., Li, Q., Zhang, L., Lin, H., Hu, J., Li, D., Shi, S., Cui, S., Zhou, J., Ji, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043768 · Cited by 121
“researchers believe that the effect is mediated by an increase in angiogenic [16], mitogenic [17], cytoprotective, anti-inflammatory, anti-apoptotic, immunosuppressive and anti-fibrogenic factors [18,19], as well as differentiation into specific cell types [20].”
BackgroundSelf-citationCell therapies for therapeutic angiogenesis: back to the bench
Sieveking, D. P., & Ng, M. K. C. (2009) · Vascular Medicine · doi:10.1177/1358863x08098698 · Cited by 110
Grajek, S., Popiel, M., Gil, L., Bręborowicz, P., Lesiak, M., Czepczyński, R., Sawinski, K., Straburzyńska‐Migaj, E., Araszkiewicz, A., Czyż, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp536 · Cited by 110
Messina, S., Mazzeo, A. T., Bitto, A., Aguennouz, M., Migliorato, A., Pasquale, M. G. D., Minutoli, L., Altavilla, D., Zentilin, L., Giacca, M., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8459com · Cited by 110
“It needs to be established whether the same cells might directly adopt a myogenic fate in the muscle or might contribute to the myogenic process in a paracrine fashion (43).”
BackgroundPeterson, K. M., Aly, A., Lerman, A., Lerman, L. O., & Rodriguez-Porcel, M. G. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.10.023 · Cited by 109
“Previous studies have shown that cells that over-express survival genes (Gnecchi et al. 2005; Gnecchi et al. 2006; Urbinati et al. 2005) or angiogenic factors (Azarnoush et al. 2005) have better cell survival capacity after transplantation.”
Background
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.